Search
for
Sort by
Research 31–60 of 780
- Androgens in postmenopausal women
- Observation of phenotypic variation among Indian women with polycystic ovary syndrome (PCOS) from Delhi and Srinagar
- Perspective Chapter: Beyond BMI – Rethinking Obesity Assessment in Women’s Health
- Beyond testosterone cypionate: evidence behind the use of nandrolone in male health and wellness
- Abstract P5-09-21: Selective androgen receptor modulators (SARMs): Enobosarm as targeted therapy for the treatment of androgen receptor-positive breast cancer
- Exploring the Role of GLP‐1 Agents in Managing Diabetic Foot Ulcers: A Narrative and Systematic Review
- Analysis of the phenotypic variants of polycystic ovarian syndrome in women of reproductive age group
- Body Composition Parameters, Carotid Intima Media Thickness and Epicardial Fat Thickness in Male Patients with Androgenetic Alopecia
- A Model for Predicting Polycystic Ovary Syndrome Using Serum AMH, Menstrual Cycle Length, Body Mass Index and Serum Androstenedione in Chinese Reproductive Aged Population: A Retrospective Cohort Study
- Correlation of cutaneous manifestations with body mass index, blood glucose, and hormonal levels in patients with polycystic ovarian disease
- Late bedtime was associated with increased androgen and reduced lean mass in women with polycystic ovary syndrome: a cross-sectional study
- The correlation between thyroid hormones, reproductive hormones, body mass index (BMI) and hirsute in Iraqi women with polycystic ovary syndrome (PCOS).
- Can resistance training improve the symptoms of polycystic ovary syndrome?
- Hair Loss With Rapid Weight Loss
- Decreased lipin 1β expression in visceral adipose tissue is associated with insulin resistance in polycystic ovary syndrome
- Genetic basis of polycystic ovary syndrome
- Pattern of body fat distribution in patients of PCOS using DEXA-based indices
- Nutritional Assessment of Selected Emerging Adult Women with Poly Cystic Ovarian Syndrome
- GLP-1 e Estética: Ozempic Face, Flacidez e Recuperação
- Endothelial Dysfunction in PCOS: Role of Obesity and Adipose Hormones
- The rationale for physiological testosterone replacement in women
- Body Composition and Characterization of Skinfold Thicknesses from Polycystic Ovary Syndrome Phenotypes. A Preliminar Case-Control Study
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- Putative role for insulin resistance in depression risk in polycystic ovary syndrome
- Prevalence of hepatic steatosis in women with polycystic ovary syndrome
- The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome
- Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities
- Effect of metformin by employing 2-hour postload insulin for measuring insulin resistance in Taiwanese women with polycystic ovary syndrome
- Role of plasminogen activator inhibitor type 1 (PAI-1) in PCOS patient
- Evaluation of the role of soluble receptors for advanced glycosylated end-products in polycystic ovarian syndrome